LCGPA Signs Preliminary Agreement to Localize Manufacture and Transfer of Knowledge of Insulin Products

The Local Content and Government Procurement Authority (LCGPA) signed a preliminary agreement with National Unified Procurement (NUPCO), SUDAIR PHARMACEUTICAL COMPANY, and Sanofi to localize the manufacture and transfer of knowledge of insulin products. The agreement was signed on the sidelines of the Global Health Forum under the patronage of the Chairman of the authority’s Board of Directors, Bandar bin Ibrahim Al-Khorayef, and the Ministers of Investment and Health, Eng. Khalid bin Abdulaziz Al-Falih and Minister of Health Fahd bin Abdulrahman Al-Jalajel, respectively.

The CEO of the authority, Abdulrahman bin Abdullah Al-Samari, said that the localization of the manufacture and transfer of knowledge of insulin products is a top priority for the health sector, adding that it will contribute to the development of local content in the pharmaceutical industry, in line with the Health Sector Transformation Program, which is one of the Kingdom’s Vision 2030 programs.

Al-Samari added that LCGPA has contributed to promoting preventive health through several quality initiatives that are consistent with the efforts of the Vaccines and Biopharmaceuticals Industry Committee and the Treatments Localization and Development Committee working towards localizing priority industries to achieve health and drug security. He expressed his appreciation for all government agencies that participated in the agreement, including the Ministry of Health and the Government Expenditure and Projects Efficiency Authority.